View of Prophylactic Intravenous Ketorolac for Prevention of Intraventricular Hemorrhage in Preterm Infants < 32 Weeks and < 1500 Grams: A Double-Blind, Randomized, Placebo-Controlled Trial

Return to Article Details Prophylactic Intravenous Ketorolac for Prevention of Intraventricular Hemorrhage in Preterm Infants < 32 Weeks and < 1500 Grams: A Double-Blind, Randomized, Placebo-Controlled Trial Download Download PDF